search returned 100 results for adalimumab, showing results 41 to 50

Medications abatacept adalimumab * baricitinib certolizumab pegol etanercept * golimumab infliximab * tocilizumab tofacitinib upadacitinib adalimumab * bimekizumab certolizumab pegol etanercept... golimumab secukinumab upadacitinib adalimumab * bimekizumab certolizumab pegol etanercept * golimumab
https://rheumatology.org.au/LinkClick.aspx?fileticket=IpfcK1lE3fY%3d&portalid=2

Rpts Item Qty Rpts Qty Rpts adalimumab 40mg/0.4ml syringe (citrate free) 12442W 12361N (PFS) adalimumab 40mg/0.4ml pen (citrate free) 12376J 12363Q (PFP) adalimumab 40mg/0.8ml syringe 9077R 9078T (PFS) adalimumab 40mg/0.8ml pen 9103D 9104E (PFP) Item Qty Rpts Item SL Code Qty & Rpts Item SL Code Qty
https://rheumatology.org.au/LinkClick.aspx?fileticket=pq6qLdJeuCY%3d

(pack) 13687J 13708L (PFP) 11218K (PFP) Item Qty Rpts Item Qty Rpts Item SL Code Qty Rpts adalimumab 40mg/0.4ml syringe 12400P 12430F (PFS) 13222X (PFS) adalimumab 40mg/0.4ml pen 12429E 12390D (PFP) 13227E (PFP) adalimumab 40mg/0.8ml syringe 8737W 8741C (PFS) 12326R (PFS) adalimumab 40mg/0.8ml pen 9099X
https://rheumatology.org.au/LinkClick.aspx?fileticket=pcYMGFb%2fva4%3d

for future test cases. Adalimumab Biosimilar E-script Glitch We have received a report from a member regarding an adalimumab biosimilar e-script issue. Despite entering the correct details
https://rheumatology.org.au/LinkClick.aspx?fileticket=VM5LUvNRR98%3d

Rpts Item Qty Rpts Qty Rpts adalimumab 40mg/0.4ml syringe (citrate free) 12442W 12361N (PFS) adalimumab 40mg/0.4ml pen (citrate free) 12376J 12363Q (PFP) adalimumab 40mg/0.8ml syringe 9077R 9078T (PFS) adalimumab 40mg/0.8ml pen 9103D 9104E (PFP) Item Qty Rpts Item SL Code Qty & Rpts Item SL Code Qty
https://rheumatology.org.au/LinkClick.aspx?fileticket=pq6qLdJeuCY%3d&portalid=2

ingredient. The PBS amended the listings for adalimumab on 1 April 2021 to include biosimilars Amgevita, Hadlima, Hyrimoz and Idacio alongside the originator brand Humira. How adalimumab... for adalimumab have not. The NPS Practice Review identified adalimumab to be the most
https://rheumatology.org.au/LinkClick.aspx?fileticket=flH2H%2beba%2fs%3d

ingredient. The PBS amended the listings for adalimumab on 1 April 2021 to include biosimilars Amgevita, Hadlima, Hyrimoz and Idacio alongside the originator brand Humira. How adalimumab... for adalimumab have not. The NPS Practice Review identified adalimumab to be the most
https://rheumatology.org.au/LinkClick.aspx?fileticket=flH2H-eba_s%3d&portalid=2

Rpts Brand Item SL code Qty Rpts adalimumab 40mg/0.8ml syringe 9033K 9034L (PFS) 9034L (PFS) 12438P (PFS) adalimumab 40mg/0.8ml pen 9101B 9102C (PFP) 9102C (PFP) 12415K (PFP) adalimumab 40mg/0.4ml syringe (citrate free) 12378L 12398M (PFS) 12398M
https://rheumatology.org.au/LinkClick.aspx?fileticket=5Grd5NUTNRI%3d

2024 Agenda items for:  Avacopan for GPA and MPA  Anifrolumab for SLE  Adalimumab for vision... on patients.  Medicines Repurposing Program – submissions.  Support PBAC with adalimumab
https://rheumatology.org.au/LinkClick.aspx?fileticket=%2bc%2f4cX%2bxOPM%3d

(pack) 13687J 13708L (PFP) 11218K (PFP) Item Qty Rpts Item Qty Rpts Item SL Code Qty Rpts adalimumab 40mg/0.4ml syringe 12400P 12430F (PFS) 13222X (PFS) adalimumab 40mg/0.4ml pen 12429E 12390D (PFP) 13227E (PFP) adalimumab 40mg/0.8ml syringe 8737W 8741C (PFS) 12326R (PFS) adalimumab 40mg/0.8ml pen 9099X
https://rheumatology.org.au/LinkClick.aspx?fileticket=uQQ7BprrC6E%3d

Page: 1 2 3 4 5 6 7 8 9 10